Nacl + Glucose Baxter (Sodium Chloride, Glucose)

Sodium chloride and glucose, the active ingredient in NaCl + Glucose Baxter, is a solution presented as an intravenous fluid for fluid and electrolyte replacement use. It helps restore plasma volume and provide energy in patients requiring intravenous therapy.

GNH USA supplies NaCl + Glucose Baxter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies, clinics and critical care units worldwide.

NaCl + Glucose Baxter is an intravenous electrolyte and carbohydrate solution used in fluid management and metabolic support.

- Dehydration: restores intravascular volume and corrects electrolyte deficits. - Hypoglycemia: provides rapid glucose to raise blood sugar levels. - Surgical peri‑operative care: maintains fluid balance and supplies energy during anesthesia. - Burn injuries: supports fluid resuscitation and energy needs.

Common Side Effects: - Local irritation at infusion site: mild redness or discomfort. - Mild hypernatremia: slight increase in serum sodium levels. - Transient hyperglycemia: temporary rise in blood glucose.

Serious or Rare Side Effects: - Severe electrolyte imbalance: marked disturbances in sodium or chloride. - Allergic reaction (anaphylaxis): rapid onset of hives, airway swelling, or hypotension. - Fluid overload leading to pulmonary edema: difficulty breathing and crackles on auscultation.

Before using NaCl + Glucose Baxter, consider the following precautions: - Assess electrolyte status: verify baseline sodium and chloride levels. - Monitor blood glucose: check levels during and after infusion. - Adjust infusion rate: reduce speed in patients with cardiac or renal impairment. - Avoid use in patients with known hypersensitivity to any component. - Store below 25°C: keep in the original container, protect from light and moisture.

NaCl + Glucose Baxter may interact with other medicines as follows:

Major Interactions (Avoid): - Concurrent hypertonic saline infusion: risk of severe hypernatremia. - High‑dose insulin therapy: may cause rapid glucose shifts and hypoglycemia.

Moderate Interactions (Monitor Closely): - Loop diuretics: may increase sodium loss, requiring electrolyte monitoring. - ACE inhibitors: monitor potassium levels due to combined effects on renal handling. - Corticosteroids: may affect glucose control, necessitating closer blood sugar checks.